• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    InDex Pharmaceuticals discontinues cobitolimod phase III program

    PR NEWSWIRE

    InDex Pharma has been granted a new patent for cobitolimod in South Korea

    PR NEWSWIRE

    InDex Pharmaceuticals announces that all patients needed for the cobitolimod dose selection milestone have completed Induction Study 1 of the phase III program CONCLUDE

    PR NEWSWIRE

    Positive results from PK study with cobitolimod` selected as one of the best abstracts for presentation

    PR NEWSWIRE

    InDex Pharma has been granted a new patent in Europe for cobitolimod

    PR NEWSWIRE

    InDex announces positive results from PK study with cobitolimod

    PR NEWSWIRE

    InDex provides information on PIII program CONCLUDE with cobitolimod

    PR NEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.